Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week

1. Diz-Lois Palomares, M.T.
2. Sánchez, Á.P.
3. Pazos, L.E.
4. Conde, B.G.
5. Macías, M.O.
6. Rey, T.V.
7. Prieto, E.E.
8. Herranz, I.M.
9. Aguirre, P.A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.17235/REED.2022.8560/2021 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus